Biogen CEO Michel Vounatsos' 2019 pay rises 12% to $18M
Biogen reports 2019 executive compensation
By ExecPay News
Published: April 20, 2020
Biogen reported fiscal year 2019 executive compensation information on April 20, 2020.
In 2019, six Biogen executives received on average a compensation package of $7.5M, a 6% decrease compared to previous year.
Average pay of disclosed executives at Biogen
Michel Vounatsos, Chief Executive Officer, received $18M in total, which increased by 12% compared to 2018. 68% of Vounatsos' compensation, or $12M, was in stock awards. Vounatsos also received $86K of change in pension value and nonqualified deferred compensation earnings, $3.9M in non-equity incentive plan, $1.4M in salary, as well as $450K in other compensation.
For fiscal year 2019, the median employee pay was $159,721 at Biogen. Therefore, the ratio of Michel Vounatsos' pay to the median employee pay was 114 to one.
Jeffrey D. Capello, Chief Financial Officer, received a compensation package of $5.8M, which increased by 30% compared to previous year. 70% of the compensation package, or $4.1M, was in stock awards.
Susan H. Alexander, Chief Legal Officer, earned $5.5M in 2019, a 14% decrease compared to previous year.
Alfred W. Sandrock, Jr, Executive Vice President, Research & Development, received $5.3M in 2019.
Michael D. Ehlers, Former Executive Vice President Research Development, earned $5.3M in 2019, a 25% decrease compared to previous year.
Chirfi Guindo, Executive Vice President, Global Product Strategy and Commercialization, received $4.7M in 2019.
Related executives
Michel Vounatsos
Biogen
Chief Executive Officer
Jeffrey Capello
Biogen
Chief Financial Officer
Susan Alexander
Biogen
Chief Legal Officer
Alfred Sandrock
Biogen
Executive Vice President, Research & Development
Chirfi Guindo
Biogen
Executive Vice President, Global Product Strategy and Commercialization
Michael Ehlers
Biogen
Former Executive Vice President Research Development
You may also like
Source: SEC filing on April 20, 2020.